Additionally, the same study demonstrated that the loss of FFAR3 is sufficient to reverse the cognitive impairment and amyloid-β (Aβ) pathology exhibited by the Tg2576 AD mouse model, which overexpresses the amyloid precursor protein (APP) carrying the Swedish mutation [51]. This evidence concerns the gene FFAR3 and Alzheimer disease.